ACSL1 and ovarian cancer: In addition, acyl-CoA synthetase long chain family member 1 (ACSL1), a regulator of fatty acid metabolism, inhibits the degradation of FSP1 by increasing its N-myristoylation, thereby antagonizing ferroptosis in ovarian cancer[111].